Fresenius Medical Care | FME - Selling And Administration Expenses


Fresenius Medical Care reported EUR744M in Selling and Administration Expenses for its fiscal quarter ending in September of 2026.





Selling And Administration Expenses Change Date
Akzo Nobel EUR 816M 17M Sep/2026
Alcon AG USD 964M 82M Jun/2026
AstraZeneca USD 4.07B 1.73B Sep/2026
Bayer EUR 4.02B 53M Sep/2026
Beiersdorf EUR 282M 11M Jun/2026
DaVita Healthcare Partners USD 423.46M 1.54M Jun/2026
Demant DKK 7.09B 1B Jun/2026
E.ON EUR -1.71B 3.63B Jun/2025
Essilor EUR 5.75B 139M Jun/2026
Fresenius EUR 823M 63M Sep/2026
Fresenius Medical Care EUR 744M 7.99M Sep/2026
Genmab DKK 205M 39M Jun/2026
Getinge SEK 2.65B 452M Dec/2024
Givaudan CHF 561M 25M Dec/2025
GlaxoSmithKline GBP 2.16B 39M Sep/2026
GN Store Nord DKK 751M 54M Sep/2026
GRIFOLS EUR 326M 37M Sep/2026
Hikma Pharmaceutical USD 288M 149M Dec/2025
Merck EUR 1.58B 11M Sep/2026
Novartis USD 3.08B 163M Sep/2026
Philips EUR 1.17B 33M Sep/2026
Roche Holding CHF 6.37B 908M Jun/2026
RWE EUR 690M 84M Mar/2025
Sanofi EUR 2.31B 325M Sep/2026
SAP EUR 2.7B 24M Sep/2026
Smith & Nephew USD 1.45B 29M Jun/2026